Print Preview Area

Candidate Antibody-Based Therapeutics Against HIV-1
BioDrugs, 05/07/2012

Gong R et al. – The authors review the in vitro and in vivo antiviral efficacies of existing HIV–1 bnmAbs, summarize the development of eAds and multispecific fusion proteins as novel types of HIV–1 inhibitors, and discuss possible strategies to generate more potent antibody–based candidate therapeutics against HIV–1, including some that could be used to eradicate the virus.

Get reports via email to claim your reading activity at MDLinx as Category 2 CME (It takes less than a minute)

Stay current on the latest literature, research and clinical news
Get special communications and offers from MDLinx and our sponsors
Receive invitations to paid market research

View Samples and Register

Stay current - Media Tool

Newsletter

RSS

Facebook

Receive free subspecialty
"5-minute updates" via email

Send the E-mail Newsletter to a Colleague

♦ Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More ♦

♦ Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More ♦

♦ Follow Us on Facebook

Search the latest
Medical Student Jobs
@MDLinx Career Center
View the full listing of physician jobs

Enter your email address and your password will be sent to you.
Email:

E-mail:
Password:
	Remember me Forgot your password?

Candidate Antibody-Based Therapeutics Against HIV-1 BioDrugs, 05/07/2012

Candidate Antibody-Based Therapeutics Against HIV-1
BioDrugs, 05/07/2012